Direct-toconsumer Disease Risk and Health Genetic Test Market
Direct-to-consumer Disease Risk and Health
Genetic Test Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Direct-to-consumer Disease Risk and Health Genetic Test Market Size and Growth
The direct-to-consumer Disease Risk and Health Genetic Test market research reports indicate a growing demand for genetic testing services. The market size is projected to reach $2.5 billion by 2025, driven by factors such as increasing awareness of personalized health solutions and advancements in genetic testing technology.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ 23andMe
◍ MyHeritage
◍ LabCorp
◍ Myriad Genetics
◍ Ancestry.com
◍ Quest Diagnostics
◍ Gene By Gene
◍ DNA Diagnostics Center
◍ Invitae
◍ IntelliGenetics
◍ Ambry Genetics
◍ Living DNA
◍ EasyDNA
◍ Pathway Genomics
◍ Centrillion Technology
◍ Xcode
◍ Color Genomics
◍ Anglia DNA Services
The Direct-to-consumer Disease Risk and Health Genetic Test Market is competitive with companies like 23andMe, MyHeritage, LabCorp, Myriad Genetics, and Ancestry.com leading the way. These companies offer genetic testing services that provide insights into disease risk and health profiles, helping grow the market.
- 23andMe: $475 million in sales revenue
- Myriad Genetics: $800 million in sales revenue
- Quest Diagnostics: $7.5 billion in sales revenue
Request Sample Report
Market Segmentation
By Application
◍ Online
◍ Offline
By Product
◍ Celiac Disease
◍ Parkinson Disease
◍ Alzheimer Disease
◍ Other
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients